title: Infliximab: an alternative treatment for refractory immune thrombocytopenic purpura related to Crohn's disease?
authors.forename: Georgia
authors.initials: G
authors.lastname: Lazaraki
authors.forename: Simeon
authors.initials: S
authors.lastname: Metallidis
authors.forename: Kleanthis
authors.initials: K
authors.lastname: Giannoulis
authors.forename: Anestis
authors.initials: A
authors.lastname: Tarpagos
authors.forename: Georgios
authors.initials: G
authors.lastname: Germanidis
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy* / Q000209:etiology; D016879:Salvage Therapy
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab